CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman
OXNARD, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”), a proprietary platform technology company, today announced the appointment of former CEO Rob Davidson to Chairman of the Board of Directors. In addition, the Company announced the appointment of Robert J. Costantino to its board of directors and he has also been appointed as the Chairman of CURE’s Audit Committee. These appointments bring decades of financial experience, as well as continuity that should enhance the company’s shareholder value initiatives and communications.
- OXNARD, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (CURE), a proprietary platform technology company, today announced the appointment of former CEO Rob Davidson to Chairman of the Board of Directors.
- In addition, the Company announced the appointment of Robert J. Costantino to its board of directors and he has also been appointed as the Chairman of CUREs Audit Committee.
- Rob Davidson was most recently CUREs Chief Executive Officer from July 2011 to July 2022 and served as Chairman of our Board until January 2019.
- Mr. Davidson was responsible for the development of several drug delivery technologies and commercial brand extensions.